惰性B细胞非霍奇金淋巴瘤患者新型冠状病毒感染防治专家共识  

Expert Consensus on the prevention and treatment of indolent B‑cell non‑Hodgkin lymphoma with novel coronavirus infection

作　　者：中国抗癌协会血液肿瘤专业委员会 中华医学会血液学分会 中国慢性淋巴增殖性疾病工作组 纪春岩[2] 李建勇[3] 邱录贵 彭宏凌[6] 朱华渊[3] 叶静静[2] Hematology Oncology Committee,Chinese Anti-Cancer Association;Chinese Society of Hematology,Chinese Medical Association;Chinese Working Group for Chronic Lymphoproliferative Disorders;Ji Chunyan;Li Jianyong;Qiu Lugui(不详;Department of Hematology,Qilu Hospital,Cheeloo College of Medicine,Shandong University,Jinan 250012,China;Department of Hematology,First Affiliated Hospital of Nanjing Medical University,Jiangsu Province Hospital,Nanjing 210029,China;State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases,Haihe Laboratory of Cell Ecosystem,Institute of Hematology&Blood Diseases Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Tianjin 300020,China;Tianjin Institutes of Health Science,Tianjin 301600,China)

机构地区：[1]不详 [2]山东大学齐鲁医院血液科,济南250012 [3]南京医科大学第一附属医院、江苏省人民医院血液科,南京210029 [4]中国医学科学院血液病医院(中国医学科学院血液学研究所)实验血液学国家重点实验室、国家血液系统疾病临床医学研究中心、细胞生态海河实验室,天津300020 [5]天津医学健康研究院,天津301600 [6]中南大学湘雅二医院血液内科

出　　处：《中华医学杂志》2023年第26期1980-1985,共6页National Medical Journal of China

摘　　要：惰性B细胞非霍奇金淋巴瘤(B‑iNHL)是一组进展相对缓慢的成熟B细胞淋巴瘤,其免疫功能低下,合并新型冠状病毒感染(COVID‑19)问题不容忽视。为指导B‑iNHL合并COVID‑19防治,中国抗癌协会血液肿瘤专业委员会、中华医学会血液学分会,中国慢性淋巴增殖性疾病工作组对B‑iNHL患者COVID‑19疫苗接种、预后、治疗等内容进行梳理形成共识,供临床医生参考。Indolent B‑cell non‑Hodgkin lymphoma(B‑iNHL)is a group of mature B‑cell lymphomas that develop slowly.It is characterized by low immune function and could be risky when complicated with novel coronavirus infection(COVID‑19).In order to guide the prevention and treatment of B‑iNHL combined with COVID‑19,China Anti‑Cancer Association Hematological malignancies Committee,the Chinese Society of Hematology Medical Association and Chinese Chronic lymphoproliferative Diseases Working Group formed consensus on COVID‑19 vaccination,prognosis,treatment and follow‑up of B‑iNHL patients for clinician reference.

关 键 词：B细胞非霍奇金淋巴瘤 惰性 新型冠状病毒感染 疫苗接种 治疗 专家共识 

分 类 号：R733.1[医药卫生—肿瘤]